Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
about
Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined RoutingNanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 1: Compositions and FeaturesEfficient hepatic delivery of drugs: novel strategies and their significanceLiposomes as nanomedical devicesComparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical modelDevelopment of a cell-based bioassay for phospholipase A2-triggered liposomal drug releasePreparation and Evaluation of Oxaliplatin Thermosensitive Liposomes with Rapid Release and High StabilityNovel delivery approaches for cancer therapeutics.Plasmin-loaded echogenic liposomes for ultrasound-mediated thrombolysis.Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablationMolecular basis of phospholipase A2 activity toward phospholipids with sn-1 substitutions.Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved.Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells.MRI contrast variation of thermosensitive magnetoliposomes triggered by focused ultrasound: a tool for image-guided local drug delivery.Photo activation of HPPH encapsulated in "Pocket" liposomes triggers multiple drug release and tumor cell killing in mouse breast cancer xenograftsA novel class of photo-triggerable liposomes containing DPPC:DC(8,9)PC as vehicles for delivery of doxorubcin to cells.Enzyme-inspired controlled release of cucurbit[7]uril nanovalves by using magnetic mesoporous silica.Low-temperature 1H-NMR spectroscopic study of doxorubicin influence on the hydrated properties of nanosilica modified by DNA.Physicochemical characterization of a PEGylated liposomal drug formulation using capillary electrophoresis.Understanding detergent effects on lipid membranes: a model study of lysolipidsLipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinicLiposomal Cu-64 labeling method using bifunctional chelators: poly(ethylene glycol) spacer and chelator effects.Drug-loaded sickle cells programmed ex vivo for delayed hemolysis target hypoxic tumor microvessels and augment tumor drug delivery.Self-assembled nanoscale coordination polymers with trigger release properties for effective anticancer therapyPeptidophospholipids: synthesis, phospholipase A2 catalyzed hydrolysis, and application to development of phospholipid prodrugs.S-layers: principles and applications.Biomimetic interfaces based on S-layer proteins, lipid membranes and functional biomoleculesEndogenous lung surfactant inspired pH responsive nanovesicle aerosols: pulmonary compatible and site-specific drug delivery in lung metastases.Rapid vaccination using an acetalated dextran microparticulate subunit vaccine confers protection against triplicate challenge by bacillus anthracis.Copper-doxorubicin as a nanoparticle cargo retains efficacy with minimal toxicity.Folate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumorModel answers to lipid membrane questionsPEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.Secretory phospholipase A₂ responsive liposomes.Nanoliposomes for encapsulation and delivery of the potential antitumoral methyl 6-methoxy-3-(4-methoxyphenyl)-1H-indole-2-carboxylate.Lipids, curvature, and nano-medicineLipophilic prodrug conjugates allow facile and rapid synthesis of high-loading capacity liposomes without the need for post-assembly purification.NIR-driven Smart Theranostic Nanomedicine for On-demand Drug Release and Synergistic Antitumour Therapy.Reduction-responsive dithiomaleimide-based nanomedicine with high drug loading and FRET-indicated drug releaseReparameterization of all-atom dipalmitoylphosphatidylcholine lipid parameters enables simulation of fluid bilayers at zero tension.
P2860
Q26746171-0323F226-215C-4E5E-801F-F9AB8DE4551AQ26798426-310D1B04-6974-4205-92AE-50229B1DE1BAQ27007518-7262E615-A02D-41AA-BB75-4C324BAD8722Q28088315-3143DAAB-F875-4926-84AC-6BABA8D5CA24Q28484470-9C917E12-F1C5-460E-A1FD-D0960BD81BF5Q28547031-8B3D9150-833E-4776-8C80-464B1628D409Q28552645-F27906B2-800D-4593-89C2-170CEA7D4369Q30368171-1EF00A31-E06D-4427-8343-3AEE6D0EDEF2Q30392562-9F3CE84F-381B-4E21-B200-BAEE21E82734Q30410530-13B7D9F8-AE7A-4DDB-80DE-1A3D38AF891FQ30440522-1F94E5DA-F1DD-4C67-95AE-57AA4B1EA27AQ30477892-6EF4BBD9-15D6-4E1D-AD9A-14E6A83C0DD7Q30488487-1C3B3932-F0CA-42A3-A024-C757F440E4FBQ30583959-8A9D2260-9A6D-41E6-9828-B780F232B30FQ30611957-0DA8A6DA-45CE-4024-9362-541093F424F4Q33651796-B6FE974C-4A7E-4E4E-A880-BF364DD4CA39Q33791006-1BA09164-FD6A-44F2-83FD-B79144FB38A7Q33810378-DC691B5D-E5C2-4BE9-A7BE-564F9ADF17FBQ33834429-78CA0012-99BC-4FBA-AEF7-17B05988B063Q33858619-9C493873-35B1-4FE3-8080-3A4C996500AEQ33911056-382D2083-51DE-4AC9-9D37-F7CAD19C5D36Q34144898-4B86A40B-6C3E-4036-88A3-67353AC72DBEQ34170303-8F5DFF69-6D77-4CD1-870C-49C231E09488Q34275000-4D88FF79-D372-4306-AA6E-A2271DF7EEE7Q34282797-F9089351-7BCA-4232-8E99-2BBE53EA7BFDQ34401298-63DDD66C-9C2D-444B-98DC-108CE45A387BQ34419414-3F7E6704-6BEA-4800-A8A8-6F18956E37F2Q34534060-1FF1292D-1450-4E6B-AE06-3AA4334BE9C0Q34564854-39B51F3A-D94B-4DFD-B319-BA015DB4EC74Q34566961-F0ACFFE6-4F9B-40DE-A04F-C84F4F71B27EQ34764419-10113F79-C7EB-4F27-8553-E15FF13E3358Q35234631-FE09AE98-9686-4DE2-BA70-9A3F3ECF52D4Q35377803-7574EF4B-F23E-4110-B2E8-150327335D9DQ35385515-AD6E69C2-81CE-4345-9799-F2D65773BA1EQ35538274-0C9C8F44-EEE4-4FB4-9474-12F862A55AB6Q35590501-FCB15BDD-DCCA-46D4-BC78-886333D48B5AQ35773072-2242B742-C73E-4139-80E6-08157D5A5AB5Q35786145-0BD11817-954A-4222-AD74-8C3FDB8BC1E9Q35800930-9F3FBB24-AB72-4371-ACCB-F1E0A59CAFE8Q35812265-1E009D77-DBA3-4FCC-AA7D-F0D47ED9A158
P2860
Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Advanced strategies in liposom ...... d tumor specific drug release.
@ast
Advanced strategies in liposom ...... d tumor specific drug release.
@en
type
label
Advanced strategies in liposom ...... d tumor specific drug release.
@ast
Advanced strategies in liposom ...... d tumor specific drug release.
@en
prefLabel
Advanced strategies in liposom ...... d tumor specific drug release.
@ast
Advanced strategies in liposom ...... d tumor specific drug release.
@en
P1476
Advanced strategies in liposom ...... nd tumor specific drug release
@en
P2093
Kent Jørgensen
Simon S Jensen
P356
10.1016/J.PLIPRES.2004.12.001
P577
2005-01-22T00:00:00Z